Results 101 to 110 of about 124,514 (155)

[Infective multiple resistance in Enterobacteriaceae].

Lijecnicki vjesnik, 1969
J, Zajc-Satler, S, Banic
openaire   +1 more source

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy. [PDF]

Open Forum Infect Dis, 2017
Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, DeHovitz J, DeHovitz J, Kreiswirth B, van Duin D, Antibacterial Resistance Leadership Group.   +16 more
europepmc   +1 more source

Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. [PDF]

Antimicrob Agents Chemother, 2018
Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, Li W, Zhang X, Liao K, Man S, Wang S, Wen H, Li B, Guo Z, Tian J, Pei F, Liu L, Zhang L, Zou C, Hu T, Cai J, Yang H, Huang J, Jia X, Huang W, Cao B, Wang H.   +30 more
europepmc   +1 more source

A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults. [PDF]

Pediatr Infect Dis J, 2019
Logan LK, Nguyen DC, Scaggs Huang FA, Qureshi NK, Charnot-Katsikas A, Bartlett AH, Zheng X, Hujer AM, Domitrovic TN, Marshall SH, Bonomo RA, Weinstein RA.   +11 more
europepmc   +1 more source

A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia. [PDF]

Saudi Med J, 2019
Alzomor OA, Alfawaz TS, Abu-Shaheen A, Alshehri MA, Al Shahrani D.   +4 more
europepmc   +1 more source

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Antimicrob Agents Chemother, 2017
King M, Heil E, Kuriakose S, Bias T, Huang V, El-Beyrouty C, McCoy D, Hiles J, Richards L, Gardner J, Harrington N, Biason K, Gallagher JC.   +12 more
europepmc   +1 more source

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis. [PDF]

Medicine (Baltimore), 2016
Ni W, Han Y, Liu J, Wei C, Zhao J, Cui J, Wang R, Liu Y.   +7 more
europepmc   +1 more source

Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis. [PDF]

Adv Ther, 2019
Bassetti M, Giacobbe DR, Patel N, Tillotson G, Massey J.   +4 more
europepmc   +1 more source